The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling.
The Florijnz Data Science Top 50 report is out! We’re excited to be recognized as one of the fastest-growing players in the Data Science market for small and medium-sized enterprises in the Netherlands.
The IGX Platform integrates SAbPred, developed at the University of Oxford, to support high-throughput de-risking of antibody discovery.
ENPICOM, an innovative bioinformatics software engineering company, announced today that Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative, research-based, commercial-stage biopharmaceutical company based in China and the U.S., has signed a subscription agreement for ENPICOM’s IGX Platform.
ENPICOM announces a new Antibody Discovery Module, empowering scientists and service providers in the antibody discovery field to analyze Sanger and NGS data independently.
The Antibody Society is an international non-profit association, founded in 2007, to represent individuals and organizations involved in antibody-related research and development. We are now pleased to announce an official corporate sponsorship of The Antibody Society.
ENPICOM